Which two intranasal steroids are preferred during pregnancy?

Budesonide and Beclomethasone are preferred intranasal steroids during pregnancy due to their safety profiles and established usage in this population. Budesonide, in particular, has been studied extensively and is categorized as a pregnancy Category B medication, indicating that no evidence of fetal harm has been observed in animal studies, and there are no adequate and well-controlled studies in pregnant women. Beclomethasone also has a favorable safety profile, making it another suitable choice.

Using these medications helps alleviate symptoms of allergic rhinitis while minimizing risks to the fetus, as managing asthma and allergic conditions is essential during pregnancy for both maternal and fetal health. The preferred status of Budesonide and Beclomethasone indicates a cautious approach, prioritizing both efficacy in symptom control and safety for the developing fetus.